Liu Feng, Wei Ren, Yin Jianhan, Shen Ming, Wu Yuanbin, Guo Wei, Sun Di
Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China.
Department of Vascular and Endovascular Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.
JVS Vasc Sci. 2022 Mar 4;3:211-218. doi: 10.1016/j.jvssci.2022.02.002. eCollection 2022.
Fluorescence contrast technology using indocyanine green (ICG) could be useful for the rapid, dynamic, and objective assessment of blood vessels and the surrounding tissues when combined with near-infrared (NIR) imaging. Although ICG is a clinically available NIR fluorescence imaging probe, it can easily aggregate and is, thus, unstable. In the present study, we examined the efficacy of a host-guest ICG-β-cyclodextrin (CD) complex, which is used in pharmaceutics to improve the water solubility, stability, and bioavailability of hydrophobic molecules, for NIR imaging after hind footpad administration in a rat model.
To verify the performance of the ICG-β-CD complex with the host-guest self-assembly method in vivo, we performed simultaneous small animal (IVIS Spectrum system; PerkinElmer, Waltham, MA) and clinical (DIGI-MIH-001 near-infrared fluorescence imaging system; Beijing Digital Precision Medical Technology Co, Ltd, Beijing, China) imaging and evaluated the fluorescent properties of the ICG-β-CD complex in the hind footpad model of Sprague-Dawley male rats.
We successfully prepared the ICG-β-CD complex. Compared with ICG, in vivo experiments showed that this complex had reduced absorbance at 710 nm and increased absorbance at 780 nm, indicating that it could prevent the dimeric aggregation of ICG, and a significantly higher fluorescence intensity at 730 nm excitation. After injection of 1.25 mg/mL of ICG or ICG-β-CD complex solutions into the rat hind footpad, fluorescent NIR lymphatic images were observed with both imaging systems. During the 12-hour observation period, the signal background ratio of ICG-β-CD showed a greater acute increase and a higher signal background ratio compared with ICG. The signal background ratio of ICG-β-CD was 125 to 100 from 260 to 540 minutes. These in vivo data suggest that ICG-β-CD has greater diffusion from the injection site and faster transport to the lymphatic system compared with ICG.
ICG-β-CD showed faster lymphatic transport than ICG, allowing for more rapid lymphatic NIR imaging. Thus, the ICG-β-CD complex might be a promising fluorescent agent for clinical lymphatic NIR imaging.
当与近红外(NIR)成像相结合时,使用吲哚菁绿(ICG)的荧光造影技术可用于对血管及其周围组织进行快速、动态和客观的评估。尽管ICG是一种临床可用的近红外荧光成像探针,但它容易聚集,因此不稳定。在本研究中,我们在大鼠模型的后足垫给药后,检测了主客体ICG-β-环糊精(CD)复合物用于近红外成像的效果,该复合物在药剂学中用于提高疏水分子的水溶性、稳定性和生物利用度。
为了在体内验证采用主客体自组装方法的ICG-β-CD复合物的性能,我们同时进行了小动物(IVIS Spectrum系统;珀金埃尔默公司,美国马萨诸塞州沃尔瑟姆)和临床(DIGI-MIH-001近红外荧光成像系统;北京数字精准医疗科技有限公司,中国北京)成像,并在Sprague-Dawley雄性大鼠的后足垫模型中评估了ICG-β-CD复合物的荧光特性。
我们成功制备了ICG-β-CD复合物。与ICG相比,体内实验表明该复合物在710nm处的吸光度降低,在780nm处的吸光度增加,这表明它可以防止ICG的二聚体聚集,并且在730nm激发下荧光强度显著更高。将1.25mg/mL的ICG或ICG-β-CD复合溶液注射到大鼠后足垫后,两种成像系统均观察到了荧光近红外淋巴图像。在12小时的观察期内,与ICG相比,ICG-β-CD的信号背景比急剧增加且更高。ICG-β-CD的信号背景比在260至540分钟时为125比100。这些体内数据表明,与ICG相比,ICG-β-CD从注射部位的扩散更大,向淋巴系统的转运更快。
ICG-β-CD显示出比ICG更快的淋巴转运,从而实现更快的淋巴近红外成像。因此,ICG-β-CD复合物可能是一种有前景的用于临床淋巴近红外成像的荧光剂。